Abstract: The present invention relates to a composition for the prevention or treatment of neurodegenerative or motor neuron diseases comprising halofuginone as an active ingredient. Specifically, in Amyotrophic Lateral Sclerosis (ALS) cell and animal models, halofuginone inhibits fibrosis induced by elevated TGF-?, enhances skeletal muscle formation, improves joint contracture, and exhibits dual effects of suppressing inflammatory responses and neuronal cell death in the central nervous system, and then, halofuginone leads to the delay in the progression of ALS symptoms, improvement in performance capabilities, and extension of survival duration. Consequently, halofuginone can be usefully utilized as an active ingredient in a composition for the prevention or treatment of neurodegenerative or motor neuron diseases including ALS.

Abstract: The present invention relates to a CLC and operation method thereof equipped with a loop seal separator using magnetic oxygen carrier particles and a magnetic separator. And more particularly, the present invention relates to a loop seal separator using magnetic oxygen carrier particles and a magnetic separator, wherein the loop seal separator comprises a duct into which the ash and magnetic oxygen carrier particles, discharged from a reducer, flow; a magnetic separator to separate the ash from the magnetic oxygen carrier particles, flowing into the duct, by magnetic material; an ash discharge pipe to discharge the ash, separated by the magnetic separator; and an oxygen-carrier-particle discharge pipe to encourage the magnetic oxygen carrier particles, separated by the magnetic separator, to flow into an oxidizer.

Abstract: The present invention relates to a fluidized bed system having a sparger capable of minimizing a blockage by solids and controlling method thereof.

Abstract: The present invention relates to a CLC and operation method thereof equipped with a loop seal separator using magnetic oxygen carrier particles and a magnetic separator. And more particularly, the present invention relates to a loop seal separator using magnetic oxygen carrier particles and a magnetic separator, wherein the loop seal separator comprises a duct into which the ash and magnetic oxygen carrier particles, discharged from a reducer, flow; a magnetic separator to separate the ash from the magnetic oxygen carrier particles, flowing into the duct, by magnetic material; an ash discharge pipe to discharge the ash, separated by the magnetic separator; and an oxygen-carrier-particle discharge pipe to encourage the magnetic oxygen carrier particles, separated by the magnetic separator, to flow into an oxidizer.

Abstract: The present invention relates to a fluidized bed system having a sparger capable of minimizing a blockage by solids and controlling method thereof.

Abstract: A method for preparing synthetic natural gas (SNG) is provided. More particularly, a method for preparing synthetic natural gas is provided, in which synthetic gas generated after fuel gasification and dust collection is subjected to a first methane synthesis reaction; only part of the gas is subjected to a water gas shift reaction and the remaining gas bypasses; the mixed gas prepared by mixing the gas passed through the water gas shift reaction and the gas bypassing the water gas shift reaction is subjected to a second methane synthesis reaction; and thereby heat of the methane synthesis reaction can be controlled and catalyst life can be lengthened.

Abstract: A method for preventing or treating a brain nervous disease includes administering to a subject in need thereof a therapeutically effective amount of a carbon nanotube, wherein the nervous disease is a brain disease or a traumatic central nervous system injury. The composition of the present invention enables patients to recover from physical damage to the brain, exhibits superior efficacy for inhibiting the onset of Parkinson's disease and strokes in animal models for Parkinson's disease and strokes, and the cytotoxic effects of beta amyloid in beta amyloid toxicity tests. Therefore, the composition of the present invention can be effectively used in the preparation of medicine for protecting cranial nerves, therapeutic agents for preventing or treating brain disease, or therapeutic agents for treating traumatic injuries to the central nervous system.

Abstract: The present invention relates to a silk protein-mimicking peptide represented by the following Formula 1, a composition for preventing or treating a brain disease, a composition for improving a brain or cognitive function and a composition for preventing or treating diseases, disorders or conditions associated with oxidative stress comprising the peptide: Gly-Xaa1-Gly-Xaa2 ??(1) wherein Xaa1 is Ala, Val, Ser, Tyr, Asp, Glu, Thr, Met, Ile, Leu, Phe, His, Lys or Arg; Xaa2 is Ala, Tyr, Val, Ser, Asp, Glu, Thr, Met, Ile, Leu, Phe, His, Lys or Arg; or Xaa2 represents Ala, Tyr, Val, Ser, Asp, Glu, Thr, Met, Ile, Leu, Phe, His, Lys or Arg residue linked to Gly-Xaa3; and Xaa3 is Tyr, Val, Ala, Ser, Asp, Glu, Thr, Met, Ile, Leu, Phe, His, Lys or Arg.

Abstract: The present invention relates to a method for preventing or treating edema or dermatitis using Glehnia littoralis Fr. Schmidt et Miquel extract. The Glehnia littoralis Fr. Schmidt et Miquel extract extracted using water, alcohol or a mixture thereof as a solvent inhibits production or secretion of cytokine regulators, the inflammatory mediators, but has no side effects such as toxicity, so that the extract can be effectively used for preventing and treating edema or different types of dermatitis accompanying inflammation.